Overview
- Presenting a state-of-the-art report on recent advances concerning Ganoderma
- Focusing on advances made over the past 20 years in the pharmacology and clinical applications of Ganoderma
- Offering new insights into development and clinical application of Ganoderma and related products
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1182)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (14 chapters)
-
Front Matter
Keywords
About this book
This book presents a state-of-the-art report on recent advances concerning Ganoderma and where the field is going. Although some older work is also cited, the main focus is on advances made over the past 20 years in the pharmacology and clinical applications of Ganoderma.
Ganoderma lucidum (Lingzhi) has been used as a traditional medicine in Asian countries to maintain health and to treat diseases for more than two thousand years. Recently, its value has been demonstrated in preventing and treating certain diseases, such as tumors, liver disorders, renal injury, hypercholesterolemia, obesity, cerebral ischemia reperfusion, bronchitis etc. In addition, laboratory and clinical studies have confirmed that the chemical components of Ganoderma, such as Ganoderma lucidum polysaccharide peptides and triterpenes isolated from the fruiting body of Ganoderma lucidum, produce diverse pharmacological effects. Ganoderma and its components play an important part in antioxidant stress, radical-scavenging, immunomodulation, and intracellular signaling regulation, and accordingly warrant further study. This book systematically reviews the latest advances in our understanding of pharmacology and clinical applications of Ganoderma, and offers researchers and graduate students valuable new insights into the pharmacology and clinical applications of Ganoderma and related products.Editors and Affiliations
About the editors
Dr. Zhibin Lin is a Professor at the Department of Pharmacology, Peking University. He is also the honorary President of the Chinese Pharmacological Society, Senior Counsellor of the China Edible Fungi Association, and Councilor of the Southeast Asia Pacific Regional Federation of Pharmacologists. Prof. Lin has been engaged in pharmacological research on Ganoderma for more than 40 years, and has also has been involved in the research, development and clinical applications of various Ganoderma products. He has published more than 100 research articles on the topic.
Dr. Baoxue Yang is Vice Dean of the School of Basic Medical Sciences, and a Professor and Director of the Department of Pharmacology, Peking University. He is an executive committee member of the Chinese Pharmacological Society and chairman of the Chinese Pharmacological Society’s Nephropharmacology Division. He is also chairman of the Lucid Ganoderma Division, China Association of Traditional Chinese Medicine. Prof. Yang’s research focuses on drug discovery, nephropharmacology and medicinal use of Ganoderma lucidum. He has published more than 160 articles in these fields and holds seven patents.
Bibliographic Information
Book Title: Ganoderma and Health
Book Subtitle: Pharmacology and Clinical Application
Editors: Zhibin Lin, Baoxue Yang
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-981-32-9421-9
Publisher: Springer Singapore
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2019
Hardcover ISBN: 978-981-32-9420-2Published: 06 December 2019
Softcover ISBN: 978-981-32-9423-3Published: 27 December 2020
eBook ISBN: 978-981-32-9421-9Published: 27 November 2019
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: VIII, 321
Number of Illustrations: 38 b/w illustrations, 49 illustrations in colour
Topics: Pharmacology/Toxicology, Molecular Medicine, Cancer Research